1 min read
Press Releases
2 min read
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)
2 min read
AGC Biologics to Participate in First-Ever BIO Digital Conference
2 min read
AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment
AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab
2 min read
AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine
2 min read
AGC Inc. Decides to Launch Voluntary Tender Offer for Shares of Molmed
2 min read